|View printer-friendly version|
|August 17, 2004 5:14 p.m.|
|Teva Announces Agreement To Acquire Pfizer's Italian Generic Pharmaceutical Operation|
Jerusalem, Israel, August 17, 2004 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has reached an agreement to acquire Pfizer's Italian generic pharmaceutical marketing company, Dorom S.r.l. The cash transaction, which is valued at up to 2.3 times sales, subject to adjustments, is expected to close in December 2004, subject to closing conditions.